Plain-English translation of NCT06396299 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This is a long-term observational study that will follow 3,680 people with atrial fibrillation (a common heart rhythm disorder) across 33 medical centers in Thailand. Researchers want to understand how antithrombotic medications — drugs that prevent blood clots — are being used in Asian patients and how these choices affect health outcomes like stroke, bleeding, and quality of life. The study is especially interested in learning whether newer, non-warfarin blood thinners are becoming more available and whether they help reduce serious side effects.
People with atrial fibrillation in Asia, particularly Thailand, face higher risks of dangerous bleeding and stroke compared to patients in Western countries. Many Asian patients aren't receiving the newer, safer blood-thinning medications because of cost concerns, even though these medications may cause fewer life-threatening bleeds. This study aims to understand current treatment patterns and their real-world impacts, so doctors can make better decisions about which medications to prescribe.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be followed for up to 3 years with check-in visits every 6 months at one of the participating medical centers in Thailand. During these visits, your doctor will review your current medications, check how you're doing, and monitor for any serious health events like stroke or bleeding. The study will track your health outcomes and ask about your quality of life, but you will continue taking whatever blood-thinning medication your doctor prescribes — this is not a study where you're assigned a new drug to try.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Thailand